MiNK Therapeutics, Inc. (INKT)
NASDAQ·Healthcare·Biotechnology
$10.35
—
Mkt Cap $55.32M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+238.2%
Consensus $35.00 vs current $10.35
NASDAQ·Healthcare·Biotechnology
$10.35
—
Mkt Cap $55.32M
No recent rating data.
Price Target (1 analysts)
$35.00
Range $35.00 – $35.00
+238.2%
Consensus $35.00 vs current $10.35